Investigating the genetic landscape of DCM in the Finnish population

Published on August 27, 2015

To explore the underlying genetic defects of dilated cardiomyopathy (DCM) we applied OS-Seq technology as a novel comprehensive diagnostic tool. Despite our increasing understanding of the genetics of DCM the genetic basis of the disease is still poorly understood. We were able to identify pathogenic variants in 47.6% of the cases with family history of DCM and in 25.6% without family history using our Pan Cardiomyopathy Panel in the analysis of 145 Finnish DCM patients. Remarkably, 53% of the significant variants found were titin (TTN) truncations. As the link between titin variants and DCM was established only recently, our study adds substantial evidence and highlights the importance of titin variants underlying DCM. Furthermore, this study showed, once again, that targeted, panel-based sequencing enables high diagnostic yields in clinical setting.

PubMed http://www.ncbi.nlm.nih.gov/pubmed/26084686

 

Duodecim 2015;131:69

Last modified: 08.27.2015

News

Blueprint Genetics expands capabilities in the detection and confirmation of difficult-to-sequence regions

Published on October 17, 2018

The latest advancement in Blueprint Genetics’ production environment involves customized sequencing solutions for difficult-to-sequence genes, designed to maximize detection of clinically relevant variants. Currently, the most extensive developments are in genes SMN1/SMN2, PKD1 and RPGR (ORF15), associated with spinal muscular atrophy, autosomal dominant polycystic kidney disease and X-linked retinitis pigmentosa,…

Read more

Subscribe to our newsletter